glp-1 and ckd Receptor Agonists Diabetic Kidney Disease: A Call of Attention to Nephrologists Preventing diabetic kidney disease progression:

Outcomes included changes in left ventricular ejection fraction (LVEF), end-diastolic volume (LVEDV), end-systolic volume (LVESV), global longitudinal strain (GLS), left ventricular mass, left atrial volume (LAV), and NT-proBNP levels

As millions of patients gain access to popular weight-loss medications, physicians and health systems face a growing landscape of liability risks they need to prepare for now.

Supports Calorie Restrictive Weight Loss* Preserve Lean Muscle Mass* Support Healthy Bone Mass* Promote Healthy Hair, Skin, and Nails* Support Healthy Cognitive Function*

Some Ozempic and GLP-1 users report feeling emotionally flat or

Growing evidence suggests that GLP-1 receptor agonists like semaglutide may offer unexpected benefits beyond weight loss, including potential migraine relief through metabolic and inflammatory pathways

This product is not intended to treat, mitigate, diagnose or cure any disease